When was Amyris founded?

Amyris was founded in 2003 and raised its 1st funding round 2 years after it was founded.

Where is Amyris located?

Amyris is headquartered in Emeryville, United States. It is registered at Emeryville, California.

How many employees does Amyris have?

As of Mar 31, 2026, the latest employee count at Amyris is 987.

Is Amyris a funded company?

Amyris is a funded company, having raised a total of $487M across 61 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2005.

When was the latest funding round of Amyris?

Amyris' latest funding was a $***** Post IPO round on Dec 29, 2022, with participation from 1 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $424M in funding in 2026 to date.

What is the annual revenue of Amyris?

Annual revenue of Amyris is $270M as on Dec 31, 2022.

Where does Amyris rank among its competitors?

Amyris ranks 7th amongst 147 active competitors, of which 68 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of Amyris?

Amyris' top competitors include Syngenta, Ginkgo Bioworks and Synthego. Among them, Antheia secured the most recent funding round in January, 2026.

Amyris - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of renewable products for industrial solutions. The company's products include consumer materials, polymers, biofuels, and lubricants. It is also developing semi-synthetic artemisinin for malaria treatment.

Social
Registered Address: Emeryville, California

Key Metrics

Founded Year

2003

Location

Emeryville, United States

Stage

Public

Total Funding

$487M in 61 rounds

Latest Funding Round

Post IPO, Dec 29, 2022, $*****

Investors

Temasek & 25 more

Ranked

7^th among 147 active competitors

Annual Revenue

$270M as on Dec 31, 2022

Employee Count

987 as on Mar 31, 2026

Investment & Acquisitions

EcoFabulous & 5 more

Similar Companies

Syngenta & 162 more

Exit Details

Public

View Amyris' full profile

Amyris is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Amyris, Inc. CIN: 550856151 , United States, Active	Dec 26, 999	$270M (As on Dec 31, 2022)	247 (As on Dec 31, 2024)	-

Amyris got listed on Sep 28, 2010.

Click here to take a look at Amyris's IPO in detail

Amyris has raised a total funding of $487M over 61 rounds. Its first funding round was on 2005. Its latest funding round was a Post IPO round on Dec 29, 2022 for $*****. 1 investor participated in its latest round. Amyris has 25 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Amyris:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 29, 2022	1315049	Post IPO	9866848	4118856	9180430	3606060
Dec 21, 2020	8536100	Post IPO	8428863	9498151	1708782	DSM
Jun 04, 2020	9256089	Post IPO	5118613	6232650	8877084	9452119

Access funding benchmarks and valuations. Sign up today!

View details of Amyris's funding rounds and investors

Amyris' employee count trend

Amyris has 987 employees as of Mar 26. Here is Amyris's employee count trend over the years:

Uncover Amyris' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Amyris include Syngenta, Ginkgo Bioworks and Synthego. Here is the list of Top 10 competitors of Amyris, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Syngenta 2000, Basel (Switzerland), Acquired	Developer of technologies and sustainable farming practices for farmers	-	Analah Ventures, Europa	75/100
2nd	Ginkgo Bioworks 2008, Boston (United States), Public	Autonomous labs for biotechnology, empowering scientists to design the living world	$796M	Viking Global Investors, Felicis Ventures ... & 53 others	74/100
3rd	Synthego 2012, Redwood City (United States), Acquired	Developer of CRISPR-engineered cell and gene therapies	$460M	8VC, RA Capital Management & 30 others	71/100
4th	Twist Bioscience 2013, San Francisco (United States), Public	Developer of a semiconductor-based DNA synthesis platform	$321M	Fidelity Investments, Foresite Capital & 39 others	70/100
5th	Codexis 2002, Redwood City (United States), Public	Developer of high-performance enzymes for drug discovery	$111M	Casdin Capital, Vivo Capital & 12 others	68/100
6th	AskBio 2001, Durham (United States), Acquired	Developer of AAV technologies for treating genetic and complex disorders	$235M	Vida Ventures, TPG & 4 others	68/100
7th	Amyris 2003, Emeryville (United States), Public	Developer of renewable products for industrial solutions	$487M	TriplePoint Capital, Hercules Capital & 24 others	68/100
8th	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
9th	Asimov 2017, Boston (United States), Series B	Provider of integrated suite for advanced genetic design and manufacturing	$237M	Andreessen Horowitz, Horizons Ventures & 11 others	65/100
10th	Modalis Therapeutics 2016, Tokyo (Japan), Public	Developer of CRISPR based therapeutics for monogenic disorders	$60.7M	Pegasus Tech Ventures, LAV Asset Management ... & 15 others	63/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Amyris's competitors? Click here to see the top ones

Amyris has not made any investments yet. Amyris has made 6 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Feb 09, 2022	Acquisition	EcoFabulous	2006	Emeryville (United States)
Aug 24, 2021	Acquisition	MG Empower	2017	London (United Kingdom)
Jun 15, 2021	Acquisition	OLIKA	2015	New York City (United States)